United States · FDA National Drug Code directory
Ozempic
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0169-4130_5e1477c5-c1b8-4fc5-af2a-83e5d356a77d
- Product NDC
- 0169-4130
- Form
- INJECTION, SOLUTION
- Composition / generic term
- semaglutide
- Labeler
- Novo Nordisk Pharmaceutical Industries, LP
- Marketing category
- NDA
- Marketing start / end (source format)
- 20200930
- Source listing expiry
- 20271231
Source-listed ingredients
- SEMAGLUTIDE — 1.34 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, PLASTIC in 1 CARTON (0169-4130-13) / 3 mL in 1 SYRINGE, PLASTIC (0169-4130-01) · 0169-4130-13
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →